In terms of the tumor-suppressive role of LCN2 in pancreatic cancer, ovarian carcinoma, and hepatocellular carcinoma, LCN2 levels are extremely high during tumorigenesis and then decrease during tumor progression. This evidence concerns the gene LCN2 and neoplasm.